AHNAK2 and lung adenocarcinoma: A study conducted by Wang et al. demonstrated that the knockdown of AHNAK2 can inhibit cell proliferation, migration, and invasion while promoting apoptosis, indicating its potential oncogenic role in the progression of lung adenocarcinoma [26].